Together, we can transform the future of cancer care.
Tracking early stage breast cancer with ultrasensitive ctDNA
Information for patients with breast cancer
Monitoring therapy response with ultrasensitive ctDNA across cancer types
Ultrasensitive ctDNA detection in early-stage lung cancer
Personalis is transforming the development of next-generation therapies.
Personalis, Inc. 6600 Dumbarton Circle Fremont, CA 94555 USA Directions and Map (Google Maps)
Monday – Friday 9 AM – 5 PM PST
Personalis U.K. Limited Squires House, 205A High Street West Wickham, Kent BR 40PH
Notifications
